Free Trial

The Allstate Co. (NYSE:ALL) Stake Reduced by GW Henssler & Associates Ltd.

Allstate logo with Finance background

GW Henssler & Associates Ltd. cut its holdings in The Allstate Co. (NYSE:ALL - Free Report) by 1.8% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 187,810 shares of the insurance provider's stock after selling 3,410 shares during the period. Allstate comprises approximately 2.0% of GW Henssler & Associates Ltd.'s investment portfolio, making the stock its 9th biggest holding. GW Henssler & Associates Ltd. owned approximately 0.07% of Allstate worth $35,618,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in ALL. SPC Financial Inc. boosted its holdings in shares of Allstate by 3.6% in the 3rd quarter. SPC Financial Inc. now owns 1,564 shares of the insurance provider's stock valued at $297,000 after buying an additional 54 shares during the last quarter. Lake Street Advisors Group LLC grew its position in shares of Allstate by 1.8% in the 3rd quarter. Lake Street Advisors Group LLC now owns 3,129 shares of the insurance provider's stock valued at $596,000 after acquiring an additional 54 shares during the period. Abacus Planning Group Inc. increased its stake in shares of Allstate by 2.4% during the 3rd quarter. Abacus Planning Group Inc. now owns 2,416 shares of the insurance provider's stock worth $458,000 after purchasing an additional 56 shares during the last quarter. Premier Path Wealth Partners LLC raised its holdings in shares of Allstate by 2.5% in the 2nd quarter. Premier Path Wealth Partners LLC now owns 2,457 shares of the insurance provider's stock valued at $392,000 after purchasing an additional 61 shares during the period. Finally, Sumitomo Life Insurance Co. lifted its stake in Allstate by 0.9% in the 3rd quarter. Sumitomo Life Insurance Co. now owns 6,567 shares of the insurance provider's stock valued at $1,245,000 after purchasing an additional 61 shares during the last quarter. Institutional investors own 76.47% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have recently commented on ALL. Morgan Stanley lifted their target price on Allstate from $202.00 to $215.00 and gave the stock an "overweight" rating in a research note on Monday, October 21st. TD Cowen raised their price objective on shares of Allstate from $193.00 to $224.00 and gave the stock a "buy" rating in a research report on Tuesday, September 3rd. Piper Sandler boosted their price objective on Allstate from $188.00 to $196.00 and gave the stock an "overweight" rating in a report on Friday, August 16th. JPMorgan Chase & Co. increased their target price on Allstate from $205.00 to $207.00 and gave the stock an "overweight" rating in a research note on Thursday, October 10th. Finally, BMO Capital Markets lifted their price target on Allstate from $205.00 to $214.00 and gave the stock an "outperform" rating in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $206.44.

Get Our Latest Report on Allstate

Allstate Price Performance

NYSE ALL traded down $2.64 on Tuesday, reaching $186.57. 1,207,078 shares of the company's stock traded hands, compared to its average volume of 1,535,908. The stock has a market cap of $49.24 billion, a PE ratio of 41.55, a P/E/G ratio of 1.74 and a beta of 0.48. The stock has a 50-day simple moving average of $188.35 and a 200 day simple moving average of $174.71. The Allstate Co. has a 12 month low of $123.42 and a 12 month high of $198.79. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.36 and a quick ratio of 0.36.

Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $0.33 by $1.28. Allstate had a return on equity of 24.05% and a net margin of 5.03%. The business had revenue of $15.71 billion during the quarter, compared to analysts' expectations of $14.04 billion. During the same quarter last year, the business posted ($4.42) EPS. The business's revenue was up 12.4% on a year-over-year basis. As a group, research analysts predict that The Allstate Co. will post 15.19 earnings per share for the current year.

Insiders Place Their Bets

In other Allstate news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the sale, the insider now owns 27,364 shares of the company's stock, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Allstate news, EVP Elizabeth Brady sold 49,481 shares of Allstate stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the transaction, the executive vice president now owns 19,163 shares of the company's stock, valued at $3,431,901.67. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the sale, the insider now directly owns 27,364 shares in the company, valued at $5,236,922.32. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 192,530 shares of company stock valued at $34,967,665. 1.80% of the stock is currently owned by corporate insiders.

Allstate Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

See Also

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Should you invest $1,000 in Allstate right now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Strong Markets Meet Rising Volatility—Are Your Investments Safe?
Analysts Bullish on AI-Powered Healthcare: Intuitive Surgical’s 30% Upside
Oracle’s Cloud Shift Pays Off: Will Momentum Continue?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines